Types segmentation classifies the device architectures that address varying pathophysiological profiles and patient compliance levels. The largest share, CPAP (continuous positive airway pressure) machines, contributes approximately 55 % of global shipments; they deliver a constant pressure stream, are cost‑effective, and dominate the market due to extensive clinical validation. BiPAP (bilevel positive airway pressure) units, accounting for roughly 20 % of sales, provide separate inspiratory and expiratory pressures, catering to patients with comorbid respiratory disorders or higher pressure requirements, thereby commanding premium pricing. APAP (auto‑adjusting positive airway pressure) devices, with an estimated 15 % share, dynamically modulate pressure based on real‑time airflow resistance, improving adherence and justifying higher margins. Oral appliance therapy, a non‑device mechanical solution, represents about 7 % of the market, primarily in mild‑to‑moderate cases, and generates revenue through dental‑practice channels. Surgical implantable systems and emerging hypoglossal nerve stimulators occupy the remaining 3 %, reflecting early‑stage adoption but high unit values. This typology clarifies how each device class contributes to total market valuation within the broader market taxonomy.
